Federal Register / Vol. 78, No. 211 / Thursday, October 31, 2013 / Notices 65321 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: October 1, 2013. 

Richard Kronick, 

Director. 

[FR Doc. 2013–25839 Filed 10–30–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with section 

10(a) of the Federal Advisory Committee 

Act, 5 U.S.C. App. 2, this notice 

announces a meeting of the National 

Advisory Council for Healthcare 

Research and Quality. 

DATES: The meeting will be held on 

Friday, November 15, 2013, from 8:30 

a.m. to 3:30 p.m. 

ADDRESSES: The meeting will be held at 

the Eisenberg Conference Center, 

Agency for Healthcare Research and 

Quality, 540 Gaither Road, Rockville, 

Maryland 20850. 

FOR FURTHER INFORMATION CONTACT: 

Jaime Zimmerman, Designated 

Management Official, at the Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850, (301) 427–1456. For press-related 

information, please contact Alison Hunt 

at (301) 427–1244. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than Friday, 

November 1, 2013. The agenda, roster, 

and minutes are available from Ms. 

Bonnie Campbell, Committee 

Management Officer, Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850. Ms. Campbell’s phone number is 

(301) 427–1554. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

The National Advisory Council for 

Healthcare Research and Quality is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to AHRQ’s 

conduct of its mission including 

providing guidance on (A) Priorities for 

health care research, (B) the field of 

health care research including training 

needs and information dissemination on 

health care quality and (C) the role of 

the Agency in light of private sector 

activity and opportunities for public 

private partnerships. 

The Council is composed of members 

of the public, appointed by the 

Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

On Friday, November 15, 2013, there 

will be a subcommittee meeting for the 

National Healthcare Quality and 

Disparities Report scheduled to begin at 

7:30 a.m. The subcommittee meeting is 

open the public. The Council meeting 

will convene at 8:30 a.m., with the call 

to order by the Council Chair and 

approval of previous Council summary 

notes. The meeting is open to the 

public. The meeting will begin with the 

AHRQ Director presenting an update on 

current research, programs, and 

initiatives. Following the Director’s 

Update, the agenda includes updates on 

Affordable Care Act implementation, 

Patient Centered Outcomes Research 

Institute and the subcommittee on 

Strategic Direction. The final agenda 

will be available on the AHRQ Web site 

a www.AHRQ.gov no later than Friday, 

November 8, 2013. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2013–25832 Filed 10–30–13; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meetings 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of Five AHRQ 

Subcommittee Meetings. 

SUMMARY: The subcommittees listed 

below are part of AHRQ’s Health 

Services Research Initial Review Group 

Committee. Grant applications are to be 

reviewed and discussed at these 

meetings. Each subcommittee meeting 

will commence in open session before 

closing to the public for the duration of 

the meeting. These meetings will be 

closed to the public in accordance with 

5 U.S.C. App. 2 section 10(d), 5 U.S.C. 

section 552b(c)(4), and 5 U.S.C. 

552b(c)(6). 

Note: Due to the Federal government 

shutdown, AHRQ is republishing its Study 

Section meetings with new dates. Please see 

below. 

DATES: See below for dates of meetings: 

1. Healthcare Safety and Quality 

Improvement Research (HSQR) 

Date: October 23–24, 2013 (Open from 

8:00 a.m. to 8:30 a.m. on October 23 

and closed for remainder of the 

meeting) 

2. Healthcare Effectiveness and 

Outcomes Research (HEOR) 

Date: October 28, 2013 (Open from 

8:30 a.m. to 9:00 a.m. on October 28 

and closed for remainder of the 

meeting) 

3. Health Care Research and Training 

(HCRT) (Telephone Conference 

Call) 

Date: October 30, 2013 (Open from 

8:00 a.m. to 8:30 a.m. on October 30 

and closed for remainder of the 

meeting) 

4. Health System and Value Research 

(HSVR) 

Date: October 31, 2013 (Open from 

8:00 a.m. to 8:30 a.m. on October 31 

and closed for remainder of the 

meeting) 

5. Healthcare Information Technology 

Research (HITR) 

Date: October 31–November 1, 2013 

(Open from 8:00 a.m. to 8:30 a.m. 

on October 31 and closed for 

remainder of the meeting) 

ADDRESSES: Meetings of Healthcare 

Safety and Quality Improvement 

Research (HSQR), Healthcare 

Effectiveness and Outcomes Research 

(HEQR), Health System and Value 

Research (HSVR), and Health System 

mstockstill on DSK4VPTVN1PROD with NOTICES

65322 Federal Register / Vol. 78, No. 211 / Thursday, October 31, 2013 / Notices 

and Value Research (HSVR) will take 

place at: Hyatt Regency Hotel Bethesda, 

One Metro Center, Bethesda, MD 20814. 

Conference Call of Health Care 

Research and Training (HCRT) meeting 

will take place at: AHRQ, (Conference 

Room TBD), 540 Gaither Road, 

Rockville, MD 20850. 

FOR FURTHER INFORMATION CONTACT: (to 

obtain a roster of members, agenda or 

minutes of the non-confidential portions 

of the meetings.) 

Mrs. Bonnie Campbell, Committee 

Management Officer, Office of 

Extramural Research Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Suite 2000, Rockville, 

Maryland 20850, Telephone (301) 427– 

1554. 

SUPPLEMENTARY INFORMATION: In 

accordance with section 10(a)(2) of the 

Federal Advisory Committee Act (5 

U.S.C. App. 2), AHRQ announces 

meetings of the scientific peer review 

groups listed above, which are 

subcommittees of AHRQ’s Health 

Services Research Initial Review Group 

Committee. Each subcommittee meeting 

will commence in open session before 

closing to the public for the duration of 

the meeting. The subcommittee 

meetings will be closed to the public in 

accordance with the provisions set forth 

in 5 U.S.C. App. 2 section 10(d), 5 

U.S.C. 552b(c)(4), and 5 U.S.C. 

552b(c)(6) The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Agenda items for these meetings are 

subject to change as priorities dictate. 

Dated: October 24, 3013. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2013–25833 Filed 10–30–13; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–14–0892] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–7570 or send 

comments to LeRoy Richardson, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an email to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Clostridium difficile Infection (CDI) 

Surveillance (0920–0892, Expiration 

07/31/2014)—Extension—National 

Center for Emerging and Zoonotic 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Steady increases in the rate and 

severity of Clostridium difficile 

infection (CDI) indicate a clear need to 

conduct longitudinal assessments to 

continue to monitor changes in CDI 

epidemiology, including changes in risk 

factors for disease, as well as increases 

The surveillance population will consist 

of persons residing in the catchment 

area of the participating Emerging 

Infections Program (EIP) sites who are 1 

year of age or older. This surveillance 

poses no more than minimal risk to the 

study participants as there will be no 

interventions or modifications to the 

care study participants receive. EIP 

surveillance personnel will perform 

active case finding from laboratory 

reports of stool specimens testing 

positive for C. difficile toxin and 

abstract data on cases using a 

standardized case report form. For a 

subset of cases (e.g., communityassociated C. difficile cases) sites will 

administer a health interview. 

CDC requests Office of Management 

and Budget (OMB) extension of 

standardized data collection for an 

additional three years. The 

epidemiology of C. difficile continues to 

evolve and incidence of disease is still 

high with no significant declines being 

observed. Continuing to understand 

what put persons at risk for C. difficile 

in the community is critical to inform 

prevention strategies. There are no 

changes in the burden estimates or data 

collection instruments from what is 

shown in the current inventory. 

A total of 600 individuals who 

develop CDI will be contacted for a 

telephone interview annually and of 

those it is estimated that 500 will meet 

study inclusion criteria. The interview 

screening is estimated to take 5 minutes 

and the full telephone interview is 

estimated to take 40 minutes. Therefore, 

the total estimated annualized burden 

for this data collection is estimated to be 

383 hours. 

There are no costs to the respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(in hrs.) 

Total burden 

(in hrs.) 

Persons in the community infected 

with C. difficile.

Screening Form ................................ 600 1 5/60 50 

Telephone Interview ......................... 500 1 40/60 333 

Total ........................................... ........................................................... ........................ ........................ ........................ 383 

mstockstill on DSK4VPTVN1PROD with NOTICES